nodes	percent_of_prediction	percent_of_DWPC	metapath
Guaifenesin—Nephrolithiasis—Sitagliptin—type 2 diabetes mellitus	0.0307	0.0327	CcSEcCtD
Guaifenesin—Calculus of kidney—Gliclazide—type 2 diabetes mellitus	0.028	0.0298	CcSEcCtD
Guaifenesin—Nephrolithiasis—Gliclazide—type 2 diabetes mellitus	0.0228	0.0243	CcSEcCtD
Guaifenesin—Discomfort—Tolazamide—type 2 diabetes mellitus	0.0147	0.0157	CcSEcCtD
Guaifenesin—Urticaria—Tolbutamide—type 2 diabetes mellitus	0.0125	0.0133	CcSEcCtD
Guaifenesin—Urticaria—Chlorpropamide—type 2 diabetes mellitus	0.0113	0.0121	CcSEcCtD
Guaifenesin—Urticaria—Tolazamide—type 2 diabetes mellitus	0.0113	0.0121	CcSEcCtD
Guaifenesin—Urticaria—Linagliptin—type 2 diabetes mellitus	0.0112	0.0119	CcSEcCtD
Guaifenesin—Rash—Miglitol—type 2 diabetes mellitus	0.011	0.0117	CcSEcCtD
Guaifenesin—Dermatitis—Miglitol—type 2 diabetes mellitus	0.011	0.0117	CcSEcCtD
Guaifenesin—Urticaria—Acarbose—type 2 diabetes mellitus	0.0109	0.0116	CcSEcCtD
Guaifenesin—Urticaria—Nateglinide—type 2 diabetes mellitus	0.0105	0.0112	CcSEcCtD
Guaifenesin—Nausea—Miglitol—type 2 diabetes mellitus	0.0104	0.011	CcSEcCtD
Guaifenesin—Rash—Tolbutamide—type 2 diabetes mellitus	0.00989	0.0105	CcSEcCtD
Guaifenesin—Headache—Tolbutamide—type 2 diabetes mellitus	0.00983	0.0105	CcSEcCtD
Guaifenesin—Discomfort—Glipizide—type 2 diabetes mellitus	0.00976	0.0104	CcSEcCtD
Guaifenesin—Dizziness—Tolazamide—type 2 diabetes mellitus	0.00944	0.01	CcSEcCtD
Guaifenesin—Dizziness—Chlorpropamide—type 2 diabetes mellitus	0.00944	0.01	CcSEcCtD
Guaifenesin—Discomfort—Pioglitazone—type 2 diabetes mellitus	0.00935	0.00995	CcSEcCtD
Guaifenesin—Nausea—Tolbutamide—type 2 diabetes mellitus	0.00932	0.00991	CcSEcCtD
Guaifenesin—Carvedilol—NPPB—type 2 diabetes mellitus	0.0092	0.153	CrCbGaD
Guaifenesin—Carvedilol—GJA1—type 2 diabetes mellitus	0.0092	0.153	CrCbGaD
Guaifenesin—Urticaria—Repaglinide—type 2 diabetes mellitus	0.00909	0.00967	CcSEcCtD
Guaifenesin—Discomfort—Sitagliptin—type 2 diabetes mellitus	0.00908	0.00966	CcSEcCtD
Guaifenesin—Vomiting—Chlorpropamide—type 2 diabetes mellitus	0.00907	0.00966	CcSEcCtD
Guaifenesin—Rash—Chlorpropamide—type 2 diabetes mellitus	0.009	0.00957	CcSEcCtD
Guaifenesin—Rash—Tolazamide—type 2 diabetes mellitus	0.009	0.00957	CcSEcCtD
Guaifenesin—Headache—Chlorpropamide—type 2 diabetes mellitus	0.00894	0.00951	CcSEcCtD
Guaifenesin—Headache—Tolazamide—type 2 diabetes mellitus	0.00894	0.00951	CcSEcCtD
Guaifenesin—Rash—Linagliptin—type 2 diabetes mellitus	0.00891	0.00948	CcSEcCtD
Guaifenesin—Dermatitis—Linagliptin—type 2 diabetes mellitus	0.0089	0.00947	CcSEcCtD
Guaifenesin—Headache—Linagliptin—type 2 diabetes mellitus	0.00885	0.00942	CcSEcCtD
Guaifenesin—Dizziness—Nateglinide—type 2 diabetes mellitus	0.00874	0.0093	CcSEcCtD
Guaifenesin—Vomiting—Acarbose—type 2 diabetes mellitus	0.00872	0.00928	CcSEcCtD
Guaifenesin—Rash—Acarbose—type 2 diabetes mellitus	0.00865	0.0092	CcSEcCtD
Guaifenesin—Dermatitis—Acarbose—type 2 diabetes mellitus	0.00864	0.00919	CcSEcCtD
Guaifenesin—Urticaria—Rosiglitazone—type 2 diabetes mellitus	0.00859	0.00914	CcSEcCtD
Guaifenesin—Nausea—Chlorpropamide—type 2 diabetes mellitus	0.00848	0.00902	CcSEcCtD
Guaifenesin—Nausea—Tolazamide—type 2 diabetes mellitus	0.00848	0.00902	CcSEcCtD
Guaifenesin—Vomiting—Nateglinide—type 2 diabetes mellitus	0.00841	0.00894	CcSEcCtD
Guaifenesin—Rash—Nateglinide—type 2 diabetes mellitus	0.00834	0.00887	CcSEcCtD
Guaifenesin—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.00833	0.00886	CcSEcCtD
Guaifenesin—Nausea—Acarbose—type 2 diabetes mellitus	0.00814	0.00867	CcSEcCtD
Guaifenesin—Nausea—Nateglinide—type 2 diabetes mellitus	0.00785	0.00836	CcSEcCtD
Guaifenesin—Urticaria—Glipizide—type 2 diabetes mellitus	0.00752	0.008	CcSEcCtD
Guaifenesin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.00728	0.00774	CcSEcCtD
Guaifenesin—Rash—Repaglinide—type 2 diabetes mellitus	0.00722	0.00768	CcSEcCtD
Guaifenesin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.00721	0.00767	CcSEcCtD
Guaifenesin—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.00721	0.00767	CcSEcCtD
Guaifenesin—Headache—Repaglinide—type 2 diabetes mellitus	0.00717	0.00763	CcSEcCtD
Guaifenesin—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.00715	0.00761	CcSEcCtD
Guaifenesin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.00702	0.00747	CcSEcCtD
Guaifenesin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.007	0.00745	CcSEcCtD
Guaifenesin—Carvedilol—HIF1A—type 2 diabetes mellitus	0.00697	0.116	CrCbGaD
Guaifenesin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.00682	0.00726	CcSEcCtD
Guaifenesin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.00681	0.00725	CcSEcCtD
Guaifenesin—Nausea—Repaglinide—type 2 diabetes mellitus	0.0068	0.00723	CcSEcCtD
Guaifenesin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.00678	0.00721	CcSEcCtD
Guaifenesin—Discomfort—Gliclazide—type 2 diabetes mellitus	0.00674	0.00718	CcSEcCtD
Guaifenesin—Alprenolol—ADRB3—type 2 diabetes mellitus	0.00673	0.112	CrCbGaD
Guaifenesin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.00642	0.00684	CcSEcCtD
Guaifenesin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.00633	0.00674	CcSEcCtD
Guaifenesin—Dizziness—Glipizide—type 2 diabetes mellitus	0.00626	0.00666	CcSEcCtD
Guaifenesin—Discomfort—Orlistat—type 2 diabetes mellitus	0.00612	0.00651	CcSEcCtD
Guaifenesin—Vomiting—Glipizide—type 2 diabetes mellitus	0.00602	0.00641	CcSEcCtD
Guaifenesin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.006	0.00638	CcSEcCtD
Guaifenesin—Rash—Glipizide—type 2 diabetes mellitus	0.00597	0.00635	CcSEcCtD
Guaifenesin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00596	0.00635	CcSEcCtD
Guaifenesin—Headache—Glipizide—type 2 diabetes mellitus	0.00593	0.00631	CcSEcCtD
Guaifenesin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.00584	0.00622	CcSEcCtD
Guaifenesin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.00582	0.0062	CcSEcCtD
Guaifenesin—Pindolol—ADRB3—type 2 diabetes mellitus	0.00579	0.0963	CrCbGaD
Guaifenesin—Urticaria—Glyburide—type 2 diabetes mellitus	0.00579	0.00616	CcSEcCtD
Guaifenesin—Headache—Pioglitazone—type 2 diabetes mellitus	0.00568	0.00605	CcSEcCtD
Guaifenesin—Discomfort—Metformin—type 2 diabetes mellitus	0.00564	0.006	CcSEcCtD
Guaifenesin—Nausea—Glipizide—type 2 diabetes mellitus	0.00562	0.00598	CcSEcCtD
Guaifenesin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.00562	0.00598	CcSEcCtD
Guaifenesin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.0056	0.00596	CcSEcCtD
Guaifenesin—Rash—Glimepiride—type 2 diabetes mellitus	0.00557	0.00593	CcSEcCtD
Guaifenesin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.00557	0.00592	CcSEcCtD
Guaifenesin—Rash—Sitagliptin—type 2 diabetes mellitus	0.00555	0.00591	CcSEcCtD
Guaifenesin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.00555	0.0059	CcSEcCtD
Guaifenesin—Headache—Glimepiride—type 2 diabetes mellitus	0.00554	0.00589	CcSEcCtD
Guaifenesin—Headache—Sitagliptin—type 2 diabetes mellitus	0.00552	0.00587	CcSEcCtD
Guaifenesin—Discomfort—Irbesartan—type 2 diabetes mellitus	0.00532	0.00567	CcSEcCtD
Guaifenesin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00527	0.00561	CcSEcCtD
Guaifenesin—Nausea—Glimepiride—type 2 diabetes mellitus	0.00525	0.00558	CcSEcCtD
Guaifenesin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.00523	0.00557	CcSEcCtD
Guaifenesin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.0052	0.00553	CcSEcCtD
Guaifenesin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00507	0.00539	CcSEcCtD
Guaifenesin—Rash—Bromocriptine—type 2 diabetes mellitus	0.00503	0.00535	CcSEcCtD
Guaifenesin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.00502	0.00534	CcSEcCtD
Guaifenesin—Discomfort—Losartan—type 2 diabetes mellitus	0.00501	0.00533	CcSEcCtD
Guaifenesin—Headache—Bromocriptine—type 2 diabetes mellitus	0.00499	0.00531	CcSEcCtD
Guaifenesin—Urticaria—Valsartan—type 2 diabetes mellitus	0.00478	0.00508	CcSEcCtD
Guaifenesin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.00473	0.00504	CcSEcCtD
Guaifenesin—Urticaria—Orlistat—type 2 diabetes mellitus	0.00472	0.00502	CcSEcCtD
Guaifenesin—Vomiting—Glyburide—type 2 diabetes mellitus	0.00463	0.00493	CcSEcCtD
Guaifenesin—Rash—Glyburide—type 2 diabetes mellitus	0.00459	0.00489	CcSEcCtD
Guaifenesin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.00459	0.00488	CcSEcCtD
Guaifenesin—Headache—Glyburide—type 2 diabetes mellitus	0.00457	0.00486	CcSEcCtD
Guaifenesin—Urticaria—Metformin—type 2 diabetes mellitus	0.00435	0.00463	CcSEcCtD
Guaifenesin—Nausea—Glyburide—type 2 diabetes mellitus	0.00433	0.00461	CcSEcCtD
Guaifenesin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.00433	0.0046	CcSEcCtD
Guaifenesin—Discomfort—Ramipril—type 2 diabetes mellitus	0.0043	0.00457	CcSEcCtD
Guaifenesin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.00416	0.00443	CcSEcCtD
Guaifenesin—Carvedilol—ADRB3—type 2 diabetes mellitus	0.00415	0.0691	CrCbGaD
Guaifenesin—Rash—Gliclazide—type 2 diabetes mellitus	0.00413	0.00439	CcSEcCtD
Guaifenesin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00412	0.00439	CcSEcCtD
Guaifenesin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.0041	0.00437	CcSEcCtD
Guaifenesin—Headache—Gliclazide—type 2 diabetes mellitus	0.0041	0.00436	CcSEcCtD
Guaifenesin—Dizziness—Valsartan—type 2 diabetes mellitus	0.00398	0.00423	CcSEcCtD
Guaifenesin—Dizziness—Orlistat—type 2 diabetes mellitus	0.00393	0.00418	CcSEcCtD
Guaifenesin—Nausea—Gliclazide—type 2 diabetes mellitus	0.00389	0.00414	CcSEcCtD
Guaifenesin—Urticaria—Losartan—type 2 diabetes mellitus	0.00386	0.00411	CcSEcCtD
Guaifenesin—Vomiting—Valsartan—type 2 diabetes mellitus	0.00382	0.00407	CcSEcCtD
Guaifenesin—Rash—Valsartan—type 2 diabetes mellitus	0.00379	0.00403	CcSEcCtD
Guaifenesin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.00379	0.00403	CcSEcCtD
Guaifenesin—Vomiting—Orlistat—type 2 diabetes mellitus	0.00378	0.00402	CcSEcCtD
Guaifenesin—Headache—Valsartan—type 2 diabetes mellitus	0.00377	0.00401	CcSEcCtD
Guaifenesin—Rash—Orlistat—type 2 diabetes mellitus	0.00375	0.00399	CcSEcCtD
Guaifenesin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.00374	0.00398	CcSEcCtD
Guaifenesin—Headache—Orlistat—type 2 diabetes mellitus	0.00372	0.00396	CcSEcCtD
Guaifenesin—Dizziness—Metformin—type 2 diabetes mellitus	0.00362	0.00385	CcSEcCtD
Guaifenesin—Nausea—Valsartan—type 2 diabetes mellitus	0.00357	0.0038	CcSEcCtD
Guaifenesin—Nausea—Orlistat—type 2 diabetes mellitus	0.00353	0.00375	CcSEcCtD
Guaifenesin—Vomiting—Metformin—type 2 diabetes mellitus	0.00348	0.0037	CcSEcCtD
Guaifenesin—Rash—Metformin—type 2 diabetes mellitus	0.00345	0.00367	CcSEcCtD
Guaifenesin—Dermatitis—Metformin—type 2 diabetes mellitus	0.00345	0.00367	CcSEcCtD
Guaifenesin—Headache—Metformin—type 2 diabetes mellitus	0.00343	0.00365	CcSEcCtD
Guaifenesin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.00342	0.00364	CcSEcCtD
Guaifenesin—Urticaria—Ramipril—type 2 diabetes mellitus	0.00331	0.00352	CcSEcCtD
Guaifenesin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.00328	0.0035	CcSEcCtD
Guaifenesin—Rash—Irbesartan—type 2 diabetes mellitus	0.00326	0.00347	CcSEcCtD
Guaifenesin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.00325	0.00346	CcSEcCtD
Guaifenesin—Nausea—Metformin—type 2 diabetes mellitus	0.00325	0.00346	CcSEcCtD
Guaifenesin—Headache—Irbesartan—type 2 diabetes mellitus	0.00324	0.00344	CcSEcCtD
Guaifenesin—Dizziness—Losartan—type 2 diabetes mellitus	0.00322	0.00342	CcSEcCtD
Guaifenesin—Propranolol—ADRB3—type 2 diabetes mellitus	0.00316	0.0525	CrCbGaD
Guaifenesin—Vomiting—Losartan—type 2 diabetes mellitus	0.00309	0.00329	CcSEcCtD
Guaifenesin—Nausea—Irbesartan—type 2 diabetes mellitus	0.00307	0.00327	CcSEcCtD
Guaifenesin—Rash—Losartan—type 2 diabetes mellitus	0.00307	0.00326	CcSEcCtD
Guaifenesin—Dermatitis—Losartan—type 2 diabetes mellitus	0.00306	0.00326	CcSEcCtD
Guaifenesin—Headache—Losartan—type 2 diabetes mellitus	0.00305	0.00324	CcSEcCtD
Guaifenesin—Nausea—Losartan—type 2 diabetes mellitus	0.00289	0.00307	CcSEcCtD
Guaifenesin—Carvedilol—VEGFA—type 2 diabetes mellitus	0.00281	0.0467	CrCbGaD
Guaifenesin—Dizziness—Ramipril—type 2 diabetes mellitus	0.00276	0.00293	CcSEcCtD
Guaifenesin—Vomiting—Ramipril—type 2 diabetes mellitus	0.00265	0.00282	CcSEcCtD
Guaifenesin—Rash—Ramipril—type 2 diabetes mellitus	0.00263	0.0028	CcSEcCtD
Guaifenesin—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00263	0.00279	CcSEcCtD
Guaifenesin—Headache—Ramipril—type 2 diabetes mellitus	0.00261	0.00278	CcSEcCtD
Guaifenesin—Nausea—Ramipril—type 2 diabetes mellitus	0.00248	0.00263	CcSEcCtD
Guaifenesin—Carvedilol—ADRA2A—type 2 diabetes mellitus	0.00188	0.0313	CrCbGaD
Guaifenesin—Ranolazine—CYP3A4—type 2 diabetes mellitus	0.00175	0.0291	CrCbGaD
Guaifenesin—Chlorphenesin—CYP3A4—type 2 diabetes mellitus	0.00167	0.0278	CrCbGaD
Guaifenesin—Chlorphenesin—PTGS2—type 2 diabetes mellitus	0.00164	0.0272	CrCbGaD
Guaifenesin—Carvedilol—CYP2E1—type 2 diabetes mellitus	0.00137	0.0228	CrCbGaD
Guaifenesin—Carvedilol—CYP1A2—type 2 diabetes mellitus	0.00131	0.0217	CrCbGaD
Guaifenesin—Propranolol—CYP1A2—type 2 diabetes mellitus	0.000993	0.0165	CrCbGaD
Guaifenesin—Carvedilol—CYP3A4—type 2 diabetes mellitus	0.000865	0.0144	CrCbGaD
Guaifenesin—Propranolol—CYP3A4—type 2 diabetes mellitus	0.000658	0.0109	CrCbGaD
